We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
NovaGold Resources
NG
$2.95B
| $257K | 0.16% |
75,000
+50,000
| +200% | +$190K |
2014 Q1
5 quarters
|
|
127
Tejon Ranch
TRC
$442M
| $257K | 0.16% |
10,300
| – | – |
2013 Q3
7 quarters
|
|
|
GRUB
128
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $256K | 0.16% |
+3,750
| New | +$304K |
2015 Q2
0 quarters
|
|
129
Curis
CRIS
$1.56M
| $254K | 0.16% |
38
| – | – |
2013 Q2
8 quarters
|
|
130
DELISTED
Nimble Storage, Inc.
NMBL
| $253K | 0.16% |
+9,000
| New | +$235K |
2015 Q2
0 quarters
|
|
131
Celldex Therapeutics
CLDX
$2.31B
| $252K | 0.16% |
667
-412
| -38% | -$164K |
2014 Q4
2 quarters
|
|
132
UNIFI
UFI
$112M
| $251K | 0.16% |
7,500
-2,500
| -25% | -$85.4K |
2013 Q2
8 quarters
|
|
|
ASNA
133
DELISTED
Ascena Retail Group, Inc.
ASNA
| $250K | 0.16% |
+750
| New | +$229K |
2015 Q2
0 quarters
|
|
134
First Northwest Bancorp
FNWB
$93.7M
| $249K | 0.15% |
20,000
| – | – |
2015 Q1
1 quarter
|
|
|
ISBC
135
DELISTED
Investors Bancorp, Inc.
ISBC
| $246K | 0.15% |
20,000
| – | – |
2014 Q2
4 quarters
|
|
136
CALL
Jefferies Financial Group
JEF
$10.4B
| $243K | 0.15% |
+11,171
| New | +$239K |
2015 Q2
0 quarters
|
|
|
BDBD
137
DELISTED
BOULDER BRANDS INC
BDBD
| $243K | 0.15% |
35,000
+10,000
| +40% | +$90.2K |
2015 Q1
1 quarter
|
|
138
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $241K | 0.15% |
7,530
-2,500
| -25% | -$63.4K |
2015 Q1
1 quarter
|
|
139
Boot Barn
BOOT
$3.63B
| $240K | 0.15% |
+7,500
| New | +$196K |
2015 Q2
0 quarters
|
|
140
Fate Therapeutics
FATE
$255M
| $239K | 0.15% |
+37,000
| New | +$221K |
2015 Q2
0 quarters
|
|
|
MYCC
141
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $239K | 0.15% |
10,000
-2,500
| -20% | -$55.2K |
2015 Q1
1 quarter
|
|
142
TherapeuticsMD
TXMD
$23.4M
| $236K | 0.15% |
+600
| New | +$212K |
2015 Q2
0 quarters
|
|
143
Investar Holding Corp
ISTR
$400M
| $228K | 0.14% |
15,000
| – | – |
2014 Q3
3 quarters
|
|
144
Iridium Communications
IRDM
$4.99B
| $227K | 0.14% |
25,000
| – | – |
2015 Q1
1 quarter
|
|
|
EVFM
145
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $225K | 0.14% |
+278
| New | +$178K |
2015 Q2
0 quarters
|
|
146
Novavax
NVAX
$2.09B
| $223K | 0.14% |
1,000
-786
| -44% | -$138K |
2013 Q4
6 quarters
|
|
147
NeoGenomics
NEO
$2.08B
| $216K | 0.13% |
40,000
| – | – |
2014 Q2
4 quarters
|
|
|
ADEP
148
CALL
DELISTED
Adept Technology Inc
ADEP
| $216K | 0.13% |
30,000
-20,000
| -40% | -$125K |
2015 Q1
1 quarter
|
|
|
CLR
149
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $212K | 0.13% |
5,000
| – | – |
2014 Q4
2 quarters
|
|
|
CVA
150
DELISTED
Covanta Holding Corporation
CVA
| $212K | 0.13% |
+10,000
| New | +$218K |
2015 Q2
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.